PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market profile: Japan
• Economy, business, and development
PART 06: Healthcare system in Japan
• Role of government
PART 07: Key insights
PART 08: Complications of infusion systems: A global perspective
• Background
• Incidence of HAIs
• CAUTIs
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by product
• General purpose or volumetric pumps
• Syringe drivers
• Patient-controlled analgesia pumps
• Ambulatory pumps
PART 11: Market segmentation by application
• Analgesia or pain management
• Diabetes
• Oncology
• Gastroenterology
• Hematology
• Pediatric or neonatology
PART 12: Market drivers
• High prevalence of chronic diseases
• Increasing use of chemotherapy
• Rise in geriatric population
• Favorable market conditions
PART 13: Impact of drivers
PART 14: Market challenges
• Complications of infusion systems
• Catheter-related bloodstream infections
• Regulatory concerns and product recalls
• Price wars
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Use of power-driven and closed infusion systems
• Availability of IT-enabled devices
• Focus on alternative site and homecare services
PART 17: Vendor landscape
• Competitive scenario
• B. Braun Melsungen
• Baxter
• BD
• Fresenius Kabi
• Hospira
• JMS
• Nipro
• Terumo
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Acceptable pressure rates for infusion systems
Exhibit 03: Maximum resistance during infusion therapy
Exhibit 04: Japan: Facts and figures
Exhibit 05: Japan: Characteristics of market
Exhibit 06: Key strategies for market entry
Exhibit 07: Advantages and disadvantages of business models for vendors
Exhibit 08: Comparison of HAI in developed and middle and low income countries
Exhibit 09: Evidence-based risk factors for CAUTIs
Exhibit 10: Infusion systems market in Japan 2015-2020 ($ millions)
Exhibit 11: Market metrics for infusion systems in japan
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of infusion systems market in Japan by product
Exhibit 14: Metrics analysis of general purpose or volumetric pumps
Exhibit 15: Metrics analysis of syringe drivers
Exhibit 16: Metrics analysis of patient-controlled analgesia pumps
Exhibit 17: Metrics analysis of ambulatory pumps
Exhibit 18: Segmentation of infusion systems market in Japan by product 2015
Exhibit 19: Segmentation of infusion systems market in Japan by application
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: B. Braun Melsungen: Key takeaways
Exhibit 23: Baxter: Key takeaways
Exhibit 24: BD: Key takeaways
Exhibit 25: Fresenius Kabi: Key takeaways
Exhibit 26: Hospira: Key takeaways
Exhibit 27: JMS: Key takeaways
Exhibit 28: Nipro: Product offerings
Exhibit 29: Nipro: Key takeaways
Exhibit 30: Terumo: Product offerings
Exhibit 31: Terumo: Key takeaways
Exhibit 32: Other prominent vendors
【掲載企業】
B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo, Animas, Medtronic, and Smiths Medical.
【資料のキーワード】
輸液装置、輸液ポンプ
【調査方法】
一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。